Biopharma start-up Helicore Biopharma has emerged from stealth with $65 million from a series A round co-led by Versant ...

Newly-launched obesity company Kailera Therapeutics has announced the appointment of Jamie Coleman as chief commercial ...

Privately-held Isotope Technologies Munich (ITM) has presented attention-grabbing positive Phase III results from a ...

Massachusetts-based radiopharmaceutical company Lantheus (Nasdaq: LNTH) has announced a plan to acquire clinical-stage ...

Shares in Swiss pharma giant Roche were more than 1% higher on Tuesday afternoon, following the announcement of positive ...

Cambridge, USA-based biotech Sage Therapeutics yesterday announced that, while rejecting an unsolicited takeover offer, its ...

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in the USA as the first HER2-directed ...

Boston, USA-based RNA focused biotech Atalanta Therapeutics today announced the completion of a $97 million Series B ...

The US Food and Drug Administration (FDA) has named Sara Brenner, a physician and senior official in its medical device ...

USA-based Neurocrine Biosciences yesterday revealed it has amended its agreement with Japanese pharma major Takeda to develop ...

US clinical-stage liver disease focused biotech Akero Therapeutics saw its shares almost double to $51.71 yesterday, after it ...

The UK sets a record 22.9% payment rate under the 2025 VPAG for branded medicines, sparking criticism from the pharma industry. The ABPI warns the increase threatens industry growth and the UK’s ...